Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 26-Jun-23 4:15 PM View:  | Kronos Bio, Inc. (KRON) | 22-Jun-23 | Grant | 11,333 | -- | -- | 431% 2.63K to 13.96K | |
| 30-Apr-21 6:55 PM View: | Acadia Pharmaceuticals Inc. (ACAD) | 30-Apr-21 | Market Option Sale | 1,032 | $20.33 | $20,980.60 | (9%) 11.59K to 10.55K | |
| 30-Apr-21 6:55 PM View: | Acadia Pharmaceuticals Inc. (ACAD) | 29-Apr-21 | Option Exercise | 3,245 | -- | -- | 39% 8.34K to 11.59K | |
| 08-Feb-21 9:00 PM View: | Acadia Pharmaceuticals Inc. (ACAD) | 04-Feb-21 | Grant | 6,490 | -- | -- | 166% 3.9K to 10.39K | |
| 08-Feb-21 9:00 PM View: | Acadia Pharmaceuticals Inc. (ACAD) | 04-Feb-21 | Market Sale | 2,051 | $50.61 | $103,801.00 | (20%) 10.39K to 8.34K | |
| 08-Jan-21 7:29 PM View: | Acadia Pharmaceuticals Inc. (ACAD) | 06-Jan-21 | Option Exercise | 2,722 | -- | -- | 124% 2.19K to 4.92K | |
| 08-Jan-21 7:29 PM View: | Acadia Pharmaceuticals Inc. (ACAD) | 06-Jan-21 | Market Option Sale | 1,016 | $53.34 | $54,193.40 | (21%) 4.92K to 3.9K | |
| 16-Oct-20 3:52 PM View: | Kronos Bio, Inc. (KRON) | 14-Oct-20 | Purchase | 2,630 | $19.00 | $49,970.00 | 100% 0 to 2.63K | |
| 01-May-20 6:00 PM View: | Acadia Pharmaceuticals Inc. (ACAD) | 30-Apr-20 | Market Option Sale | 1,050 | $49.22 | $51,681.00 | (32%) 3.25K to 2.19K | |
| 01-May-20 6:00 PM View: | Acadia Pharmaceuticals Inc. (ACAD) | 29-Apr-20 | Option Exercise | 13,245 | $18.97 | $251,200.00 | 100% 0 to 13.24K | |
| 01-May-20 6:00 PM View: | Acadia Pharmaceuticals Inc. (ACAD) | 29-Apr-20 | Market Option Sale (Planned) | 10,000 | $50.74 | $507,353.00 | (76%) 13.24K to 3.25K | |
| 11-Dec-19 6:29 PM View: | Acadia Pharmaceuticals Inc. (ACAD) | 09-Dec-19 | Option Exercise | 36,000 | $15.81 | $569,160.00 | 100% 0 to 36.0K | |
| 11-Dec-19 6:29 PM View: | Acadia Pharmaceuticals Inc. (ACAD) | 09-Dec-19 | Market Option Sale (Planned) | 36,000 | $49.66 | $1,787,850.00 | (100%) 36.0K to 0 |